Federal Act
on Medicinal Products and Medical Devices
(Therapeutic Products Act, TPA)


Open article in different language:  DE  |  FR  |  IT
Art. 67b Publication of clinical trial results 186

1 The Fed­er­al Coun­cil may, tak­ing in­to ac­count in­ter­na­tion­ally re­cog­nised reg­u­la­tions, provide that the res­ults of clin­ic­al tri­als car­ried out with a view to de­vel­op­ing a medi­cin­al product for hu­man use shall be pub­lished after the au­thor­isa­tion de­cision.

2 For this pur­pose, the Con­fed­er­a­tion may op­er­ate a data­base or have it op­er­ated by third parties. This data­base may not con­tain any data that would al­low any ref­er­ence to per­sons par­ti­cip­at­ing in clin­ic­al tri­als.

3 The Fed­er­al Coun­cil:

a.
des­ig­nates the au­thor­ity re­spons­ible for main­tain­ing the data­base;
b.
spe­cifies the du­ties and pro­ced­ure with re­gard to pub­lic­a­tion;
c.
de­term­ines the con­tent and form of the res­ults to be pub­lished;
d.
de­term­ines the re­quire­ments for the con­tent and op­er­a­tion of the data­base;
e.
reg­u­lates the ac­cess to and use of the data.

186 In­ser­ted by No I of the FA of 18 March 2016, in force since 1 Jan. 2019 (AS 2017 2745, 2018 3575; BBl 2013 1).

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden